Healthcare provider profile · identity verified

Michael S Depaolo, D.O.

Family Practice · WIND GAP, PA · NPI 1891892618

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	485	121
Metformin Hcl	Metformin Hcl	389	98
Levothyroxine Sodium	Levothyroxine Sodium	377	93
Amlodipine Besylate	Amlodipine Besylate	371	104
Meloxicam	Meloxicam	309	69
Pantoprazole Sodium	Pantoprazole Sodium	274	67
Lisinopril	Lisinopril	272	75
Simvastatin	Simvastatin	250	62
Metoprolol Succinate	Metoprolol Succinate	226	51
Gabapentin	Gabapentin	196	49
Albuterol Sulfate Hfa	Albuterol Sulfate	181	50
Losartan Potassium	Losartan Potassium	175	50
Hydrochlorothiazide	Hydrochlorothiazide	168	47
Metoprolol Tartrate	Metoprolol Tartrate	156	34
Montelukast Sodium	Montelukast Sodium	154	44
Alprazolam	Alprazolam	153	40
Omeprazole	Omeprazole	146	37
Allopurinol	Allopurinol	135	31
Eliquis	Apixaban	129	21
Rosuvastatin Calcium	Rosuvastatin Calcium	122	35
Famotidine	Famotidine	121	26
Sertraline Hcl	Sertraline Hcl	120	32
Pravastatin Sodium	Pravastatin Sodium	116	30
Tamsulosin Hcl	Tamsulosin Hcl	111	30
Lorazepam	Lorazepam	110	27
Prednisone	Prednisone	109	90
Pioglitazone Hcl	Pioglitazone Hcl	105	25
Citalopram Hbr	Citalopram Hydrobromide	103	21
Escitalopram Oxalate	Escitalopram Oxalate	103	29
Duloxetine Hcl	Duloxetine Hcl	101	23
Tramadol Hcl	Tramadol Hcl	92	30
Glimepiride	Glimepiride	90	26
Ezetimibe	Ezetimibe	89	20
Furosemide	Furosemide	89	27
Methocarbamol	Methocarbamol	86	24
Azithromycin	Azithromycin	82	74
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	82	29
Oxybutynin Chloride	Oxybutynin Chloride	82	17
Potassium Chloride	Potassium Chloride	68	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	18
Glipizide Er	Glipizide	64	16
Valsartan	Valsartan	64	15
Torsemide	Torsemide	63	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	62	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	17
Cholestyramine	Cholestyramine (With Sugar)	59	15
Alendronate Sodium	Alendronate Sodium	58	17
Synthroid	Levothyroxine Sodium	56	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	55	50
Doxazosin Mesylate	Doxazosin Mesylate	55	15
Esomeprazole Magnesium	Esomeprazole Magnesium	55	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	54	40
Bupropion Xl	Bupropion Hcl	52	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	27
Trazodone Hcl	Trazodone Hcl	51	15
Donepezil Hcl	Donepezil Hcl	48	17
Cephalexin	Cephalexin	47	24
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	46	21
Quetiapine Fumarate	Quetiapine Fumarate	45	14
Glipizide	Glipizide	44	12
Paroxetine Hcl	Paroxetine Hcl	44	12
Spironolactone	Spironolactone	44	12
Mirtazapine	Mirtazapine	41	suppressed
Celecoxib	Celecoxib	40	11
Fluticasone Propionate	Fluticasone Propionate	39	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	39	12
Amoxicillin	Amoxicillin	38	36
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	12
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	15
Single Use Swab	Alcohol Antiseptic Pads	35	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Meclizine Hcl	Meclizine Hcl	34	18
Pregabalin	Pregabalin	34	suppressed
Atenolol	Atenolol	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Symbicort	Budesonide/Formoterol Fumarate	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	27
Buspirone Hcl	Buspirone Hcl	28	suppressed
Carvedilol	Carvedilol	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	24	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	24	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Nabumetone	Nabumetone	24	suppressed
Klor-Con M20	Potassium Chloride	23	suppressed
Tradjenta	Linagliptin	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Potassium Citrate Er	Potassium Citrate	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Diazepam	Diazepam	20	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	20	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Finasteride	Finasteride	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Calcitriol	Calcitriol	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Ozempic	Semaglutide	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	14	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	11
Eletriptan Hbr	Eletriptan Hydrobromide	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Imipramine Hcl	Imipramine Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error